Fundraising Fox
Infiniplex
2 known investors
Find your way into Infiniplex
Sign up to see every warm intro you have to Infiniplex
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Infiniplex team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Infiniplex is a precision oncology company developing InfiniplexDX, a liquid biopsy platform that uses proprietary primer design and molecular-switch chemistry with software-based signal analysis to detect cancer mutations in blood and urine on standard PCR instruments. It targets five clinical indications (bladder cancer, myelodysplastic syndromes, pancreatic, colorectal, and non-small cell lung cancer) to support treatment decisions without tissue biopsies.
Founders & leadership
Investors · 2
How we know: Bosch Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Terra Venture Partners's portfolio page · funding news · press coverage · Not right? Tell us
Frequently asked questions
- What does Infiniplex do?
- Infiniplex is a precision oncology company developing InfiniplexDX, a liquid biopsy platform that uses proprietary primer design and molecular-switch chemistry with software-based signal analysis to detect cancer mutations in blood and urine on standard PCR instruments. It targets five clinical indications (bladder cancer, myelodysplastic syndromes, pancreatic, colorectal, and non-small cell lung cancer) to support treatment decisions without tissue biopsies.
- Who are Infiniplex's investors?
- Infiniplex's investors include Bosch Ventures, Terra Venture Partners.